NO167385C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzazecinderivater. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzazecinderivater.

Info

Publication number
NO167385C
NO167385C NO870280A NO870280A NO167385C NO 167385 C NO167385 C NO 167385C NO 870280 A NO870280 A NO 870280A NO 870280 A NO870280 A NO 870280A NO 167385 C NO167385 C NO 167385C
Authority
NO
Norway
Prior art keywords
chloro
preparation
benzazecine
therapeutic active
cpds
Prior art date
Application number
NO870280A
Other languages
English (en)
Norwegian (no)
Other versions
NO870280L (no
NO870280D0 (no
NO167385B (no
Inventor
Werner Aschwanden
Rene Imhof
Roland Jakob
Emilio Kyburz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO870280D0 publication Critical patent/NO870280D0/no
Publication of NO870280L publication Critical patent/NO870280L/no
Publication of NO167385B publication Critical patent/NO167385B/no
Publication of NO167385C publication Critical patent/NO167385C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/02Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/10Aza-phenanthrenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D227/00Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
    • C07D227/02Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D227/06Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D227/08Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO870280A 1986-01-23 1987-01-22 Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzazecinderivater. NO167385C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH26686 1986-01-23

Publications (4)

Publication Number Publication Date
NO870280D0 NO870280D0 (no) 1987-01-22
NO870280L NO870280L (no) 1987-07-24
NO167385B NO167385B (no) 1991-07-22
NO167385C true NO167385C (no) 1991-10-30

Family

ID=4183090

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870280A NO167385C (no) 1986-01-23 1987-01-22 Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzazecinderivater.

Country Status (30)

Country Link
US (4) US4732979A (pt)
EP (1) EP0230967B1 (pt)
JP (1) JPS62169770A (pt)
KR (1) KR910000659B1 (pt)
CN (1) CN1013111B (pt)
AT (1) ATE68790T1 (pt)
AU (1) AU590042B2 (pt)
CS (1) CS258147B2 (pt)
DD (1) DD264431A5 (pt)
DE (1) DE3773950D1 (pt)
DK (1) DK35887A (pt)
FI (1) FI82931C (pt)
GB (1) GB2185744B (pt)
HU (1) HU197883B (pt)
IE (1) IE870167L (pt)
IL (1) IL81317A (pt)
IS (1) IS3190A7 (pt)
MC (1) MC1795A1 (pt)
MT (1) MTP996B (pt)
MW (1) MW187A1 (pt)
NO (1) NO167385C (pt)
NZ (1) NZ218987A (pt)
OA (1) OA08469A (pt)
PH (1) PH22879A (pt)
PL (1) PL263796A1 (pt)
PT (1) PT84181B (pt)
TN (1) TNSN87006A1 (pt)
YU (1) YU7087A (pt)
ZA (1) ZA87407B (pt)
ZW (1) ZW1087A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81317A (en) * 1986-01-23 1991-06-30 Hoffmann La Roche 1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing them
IN167395B (pt) * 1987-07-21 1990-10-20 Hoffmann La Roche
EP0591583B1 (en) * 1991-08-21 2001-12-19 Eli Lilly And Company Benzo (f) quinolinones as 5-alpha-reductase inhibitors
US5250539A (en) * 1991-08-21 1993-10-05 Eli Lilly And Company Hexahydrobenzo[f]quinolinones
US5239075A (en) * 1991-08-21 1993-08-24 Eli Lilly And Company Process for the preparation of benzo (f) quinolinones
ES2125884T3 (es) * 1991-08-21 1999-03-16 Lilly Co Eli Hexahidrobenzo(f)quinolinonas como inhibidores de la 5-alfa-reductasa.
WO1994022444A1 (en) * 1993-03-29 1994-10-13 Smithkline Beecham Corporation Tricyclic compounds for inhibiting platelet aggregation
GB9317314D0 (en) * 1993-08-20 1993-10-06 Smithkline Beecham Corp Compounds
DK0782573T3 (da) 1994-09-20 2000-06-05 Univ California Brefeldin og analoger til forbedret synaptisk transmission
US20050067341A1 (en) * 2003-09-25 2005-03-31 Green Dennis H. Continuous production membrane water treatment plant and method for operating same
US7094331B2 (en) * 2003-11-05 2006-08-22 Marathon Ashland Petroleum Llc Viscosity modification of heavy hydrocarbons using dihydric alcohols
US20090263439A1 (en) * 2008-04-18 2009-10-22 The Procter & Gamble Company Antimicrobial Preservative Free Wipe
CN106117028B (zh) * 2016-06-14 2019-01-01 浙江永太药业有限公司 一种制备卤代-3,4-二氢-1h-2-萘酮的工艺方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE442586A (pt) * 1940-07-31
JPS5129710B2 (pt) * 1972-09-09 1976-08-27
US4341786A (en) * 1981-03-02 1982-07-27 Smithkline Corporation Pharmaceutical compositions and method of producing central alpha1 agonist activity utilizing octahydrobenzo[f]quinoline compounds
US4521423A (en) * 1983-10-31 1985-06-04 Ayerst, Mckenna & Harrison, Ltd. 7,8,9,10-Tetrahydrobenzo[h]quinolin-9-amine derivatives and compositions and methods for treating depression employing them
IL81317A (en) * 1986-01-23 1991-06-30 Hoffmann La Roche 1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ZA87407B (en) 1987-09-30
PT84181B (pt) 1989-09-14
CS258147B2 (en) 1988-07-15
GB2185744A (en) 1987-07-29
EP0230967A3 (en) 1988-08-31
JPS62169770A (ja) 1987-07-25
US4732979A (en) 1988-03-22
TNSN87006A1 (fr) 1990-01-01
MTP996B (en) 1987-08-21
CS41887A2 (en) 1987-11-12
IL81317A (en) 1991-06-30
NO870280L (no) 1987-07-24
CN1013111B (zh) 1991-07-10
PT84181A (pt) 1987-02-01
CN87100312A (zh) 1987-09-09
US4749791A (en) 1988-06-07
IL81317A0 (en) 1987-08-31
MW187A1 (en) 1987-10-14
GB8701416D0 (en) 1987-02-25
FI82931C (fi) 1991-05-10
AU6791187A (en) 1987-07-30
US4876340A (en) 1989-10-24
DD264431A5 (de) 1989-02-01
IS3190A7 (is) 1987-07-24
NZ218987A (en) 1990-04-26
PH22879A (en) 1989-01-19
ATE68790T1 (de) 1991-11-15
ZW1087A1 (en) 1987-08-12
FI82931B (fi) 1991-01-31
EP0230967B1 (de) 1991-10-23
HU197883B (en) 1989-06-28
DE3773950D1 (de) 1991-11-28
OA08469A (fr) 1988-07-29
DK35887A (da) 1987-07-24
YU7087A (en) 1988-06-30
AU590042B2 (en) 1989-10-26
FI870220A (fi) 1987-07-24
DK35887D0 (da) 1987-01-22
US4957911A (en) 1990-09-18
NO870280D0 (no) 1987-01-22
EP0230967A2 (de) 1987-08-05
KR910000659B1 (ko) 1991-01-31
IE870167L (en) 1987-07-23
NO167385B (no) 1991-07-22
GB2185744B (en) 1989-12-06
KR870007132A (ko) 1987-08-17
PL263796A1 (en) 1988-10-27
FI870220A0 (fi) 1987-01-20
MC1795A1 (fr) 1987-10-22
HUT44519A (en) 1988-03-28

Similar Documents

Publication Publication Date Title
NO167385C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzazecinderivater.
NO832794L (no) Mellomprodukter for fremstilling av omeprazoler
NO169492C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2',3'-dideoksy-2'-fluornukleosider
LU88790I2 (fr) Moxidectin et ses dérivés pharmaceutiquement acceptables
ATE82294T1 (de) Therapeutische nukleoside.
KR900701756A (ko) 축합된 피라졸 3-옥소-프로판니트릴 유도체 및 이의 제조방법
GR3005176T3 (pt)
NO179205C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1-piperidinylalkanoylarylsulfonamidderivater
NO174963C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider
FI870974A (fi) Nya foereningar, vilka aer mellanprodukter vid framstaellning av terapeutiskt anvaendbara ortokondenserade pyrrolderivat.